Search

A multidisciplinary team at Memorial Sloan Kettering Cancer Center (MSK) has developed a proof-of-concept crisis ventilator intended to provide lifesaving breathing assistance to patients requiring it when more-sophisticated respiratory support equipment is unavailable.

… Thursday, April 23, 2020 VIDEO | 00:00:12 Crisis Vent Video Details A multidisciplinary team at Memorial Sloan Kettering Cancer Center (MSK) has developed a proof-of-concept crisis ventilator intended to provide lifesaving breathing assistance to patients requiring it when more-sophisticated respiratory

GSK students, alumni, faculty, and guest speakers enjoyed two days of presentations, panel discussions, a poster session, recreation and socializing at the school’s fourth biennial retreat.

… Monday, June 6, 2016 MSK President and CEO Craig Thompson MSK President and CEO Craig Thompson gives a talk at the retreat about his work in cancer metabolism. GSK alumnus John Maciejowkski talks with GSK Dean Ken Marians and Charles Rudin GSK alumnus John Maciejowkski talks with GSK Dean Ken Marians

Medical oncologist Chau Dang explains that patients living with metastatic breast cancer have more treatment options than ever before.

… Thursday, October 27, 2016 Summary Metastatic breast cancer is a challenging disease to treat, and for that reason there are many efforts focused on helping patients to live longer and with fewer side effects. Thanks to advances in clinical care, patients with metastatic breast cancer have more treatment

Simon Powell leads the Department of Radiation Oncology and focuses in his research on the treatment of breast cancer, including the role of DNA repair deficiencies in breast cancer and breast cancer genetics.

… Friday, January 24, 2014 Summary Simon Powell leads the Department of Radiation Oncology and focuses in his research on the treatment of breast cancer, including the role of DNA repair deficiencies in breast cancer and breast cancer genetics. Simon Powell, Chair of the Department of Radiation Oncology

MSK is a founding member of Break Through Cancer, a newly launched foundation aimed at accelerating collaborative research, clinical trials, and cures for the deadliest cancers.

… Thursday, February 25, 2021 MSK today announced it is a founding member of Break Through Cancer , a newly launched foundation aimed at accelerating collaborative research, clinical trials, and cures for the deadliest cancers. The foundation is being launched with a $250 million matching gift challenge

A Memorial Sloan Kettering Cancer Center study suggests that a new, experimental treatment could make bone marrow and stem cell transplantation more effective and safe.

… Saturday, December 10, 2011 A Memorial Sloan Kettering Cancer Center study suggests that a new, experimental treatment could make bone marrow and stem cell transplantation more effective and safe. Improving the effectiveness of such transplants, while at the same time reducing side effects, is an important

TV anchor Al Roker discusses his own prostate cancer experiences, disparities in cancer care and outcomes for people of color, the importance of cancer screening for Black men, and more with Dr. Carol Brown, a gynecological oncology surgeon at Memorial Sloan Kettering and Nicholls-Biondi Chair for Health Equity at Memorial Sloan Kettering.

… Friday, February 12, 2021 VIDEO | 05:26 Health Equity and Cancer — A Conversation with Al Roker and Dr. Carol Brown Watch this video to hear NBC's Al Roker and MSK's Dr. Carol Brown discuss health disparities. Video Details When beloved TV anchor Al Roker of NBC News’ TODAY publicly announced that he

Targeting the cancer environment, rather than the cancer itself, could be a new avenue for immunotherapy.

… Wednesday, October 21, 2020 Summary Two MSK-led studies published in the journal Nature support the idea of using immunotherapy drugs to treat the environment surrounding a tumor as an indirect way to combat cancer. Despite the remarkable successes of immune-based treatments for cancer, not everyone

Learn about MSK thoracic surgeon Valerie Rusch and her approach to treating people with lung cancer and other tumors of the chest.

… Wednesday, August 28, 2019 Summary In an interview, MSK thoracic surgeon Valerie Rusch discusses her career path, her commitment to her patients, and her experiences as a woman in a male-dominated field. Valerie Rusch is Vice Chair for Clinical Research in the Department of Surgery at MSK. She is a thoracic

Research shows that TIL therapy, an emerging type of immunotherapy, works in some patients with non-small cell lung cancer.

… Wednesday, May 1, 2024 There is evidence that an emerging type of immunotherapy called TIL therapy may be successful in treating more solid tumors . Research published in Cancer Discovery shows this treatment works in some patients with non-small cell lung cancer . The lead researcher of the multicenter